Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxic...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ba1f95710e8b40e4b3ba3fc05ee9b3ae |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ba1f95710e8b40e4b3ba3fc05ee9b3ae2021-12-02T15:07:58ZOutcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey10.1038/s41598-018-29040-22045-2322https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae2018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29040-2https://doaj.org/toc/2045-2322Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxicity were retrospectively collected. Patients were diagnosed a non-metastatic rectal cancer between 2004 and 2015, and were treated at least with radiotherapy. OS was correlated with patient, tumor and treatment characteristics with univariate and multivariate analyses. Data of 593 consecutive non-metastatic rectal cancer patients were analyzed. Median follow-up was 41 months. Median OS was 9 years. Radiotherapy was delivered in pre-operative (n = 477, 80.5%), post-operative (n = 75, 12.6%) or exclusive (n = 41, 6.9%) setting. In the whole set of patients, age, nutritional condition, tumor stage, tumor differentiation, and surgery independently influenced OS. For patients experiencing surgery, OS was influenced by age, tumor differentiation and nodal status. Surgical resection is the cornerstone treatment for locally-advanced rectal cancer. Poor tumor differentiation and node involvement were identified as major predictive factor of poor OS. The research in treatment intensification and in identification of radioresistance biomarkers should therefore probably be focused on this particular subset of patients.Julien Langrand-EscurePeng DiaoMax-Adrien GarciaGuoping WangJean-Baptiste GuySophie EspenelElodie GuillaumeAmel Rehailia-BlanchardGrégoire PignéGuy de LarocheDavid KaczmarekThierry MuronJack PorcheronJean-Marc PhelipAlexis VallardNicolas MagnéNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Julien Langrand-Escure Peng Diao Max-Adrien Garcia Guoping Wang Jean-Baptiste Guy Sophie Espenel Elodie Guillaume Amel Rehailia-Blanchard Grégoire Pigné Guy de Laroche David Kaczmarek Thierry Muron Jack Porcheron Jean-Marc Phelip Alexis Vallard Nicolas Magné Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
description |
Abstract This retrospective study was undertaken to provide more modern data of real-life management of non-metastatic rectal cancer, to compare therapeutic strategies, and to identify prognostic factors of overall survival (OS) in a large cohort of patients. Data on efficacy and on acute/late toxicity were retrospectively collected. Patients were diagnosed a non-metastatic rectal cancer between 2004 and 2015, and were treated at least with radiotherapy. OS was correlated with patient, tumor and treatment characteristics with univariate and multivariate analyses. Data of 593 consecutive non-metastatic rectal cancer patients were analyzed. Median follow-up was 41 months. Median OS was 9 years. Radiotherapy was delivered in pre-operative (n = 477, 80.5%), post-operative (n = 75, 12.6%) or exclusive (n = 41, 6.9%) setting. In the whole set of patients, age, nutritional condition, tumor stage, tumor differentiation, and surgery independently influenced OS. For patients experiencing surgery, OS was influenced by age, tumor differentiation and nodal status. Surgical resection is the cornerstone treatment for locally-advanced rectal cancer. Poor tumor differentiation and node involvement were identified as major predictive factor of poor OS. The research in treatment intensification and in identification of radioresistance biomarkers should therefore probably be focused on this particular subset of patients. |
format |
article |
author |
Julien Langrand-Escure Peng Diao Max-Adrien Garcia Guoping Wang Jean-Baptiste Guy Sophie Espenel Elodie Guillaume Amel Rehailia-Blanchard Grégoire Pigné Guy de Laroche David Kaczmarek Thierry Muron Jack Porcheron Jean-Marc Phelip Alexis Vallard Nicolas Magné |
author_facet |
Julien Langrand-Escure Peng Diao Max-Adrien Garcia Guoping Wang Jean-Baptiste Guy Sophie Espenel Elodie Guillaume Amel Rehailia-Blanchard Grégoire Pigné Guy de Laroche David Kaczmarek Thierry Muron Jack Porcheron Jean-Marc Phelip Alexis Vallard Nicolas Magné |
author_sort |
Julien Langrand-Escure |
title |
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
title_short |
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
title_full |
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
title_fullStr |
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
title_full_unstemmed |
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
title_sort |
outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/ba1f95710e8b40e4b3ba3fc05ee9b3ae |
work_keys_str_mv |
AT julienlangrandescure outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT pengdiao outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT maxadriengarcia outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT guopingwang outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT jeanbaptisteguy outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT sophieespenel outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT elodieguillaume outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT amelrehailiablanchard outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT gregoirepigne outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT guydelaroche outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT davidkaczmarek outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT thierrymuron outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT jackporcheron outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT jeanmarcphelip outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT alexisvallard outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey AT nicolasmagne outcomeandprognosticfactorsin593nonmetastaticrectalcancerpatientsamonoinstitutionalsurvey |
_version_ |
1718388344395661312 |